ARM
LBMH

Adirondack Research & Management’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Adirondack Research & Management’s Portfolio LBMH Stock Details LBMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-121,497
Closed -$352K – 100
2014
Q4 		$352K Buy
121,497
+61,389
+102% +$173K 0.13% 93
2014
Q3 		$188K Buy
+60,108
New +$190K 0.07% 97

Other funds holding LBMH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adirondack Research & Management's LBMH Position: Q1 2015 in Review

Adirondack Research & Management sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2015, closing a stake of 121,497 shares — an estimated $352K sold.

Adirondack Research & Management first reported a position in LBMH in Q3 2014 and held it in 2 quarters. The position peaked at $352K in Q4 2014. 56 funds tracked by Wall St. Rank hold LBMH as of Q1 2015.

  • Adirondack Research & Management reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2015 after selling out during the quarter.
  • Adirondack Research & Management sold 121,497 LIBERATOR MED HLDGS INC (NY) shares in Q1 2015, an estimated $352K.
  • Adirondack Research & Management first reported a position in LIBERATOR MED HLDGS INC (NY) in Q3 2014 and held it in 2 quarters.
  • Adirondack Research & Management's LIBERATOR MED HLDGS INC (NY) position peaked at $352K in Q4 2014.
  • 56 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2015.

Based on Adirondack Research & Management's 13F filing for Q1 2015, filed 14 May 2015.